Intraperitoneal hyperthermic perfusion with mitomycin C for colorectal cancer with peritoneal metastases

Annals of Surgical Oncology

Volumn 3, Issue 1, 1996, Pages 44-50

  Schneebaum, Schlomo ^a,c   Arnold, Mark W ^b   Staubus, Alfred ^b   Young, Donn C ^c   Dumond, David ^b   Martin Jr , Edward W ^a  

^a Division of Surgical Oncology   (United States)

^b Department of Surgery ^*  (United States)

^c THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

Colorectal cancer; Hyperthermia; Intraperitoneal chemotherapy; Mitomycin C; Peritoneal metastasis

Indexed keywords

ANTINEOPLASTIC ANTIBIOTIC; CARCINOEMBRYONIC ANTIGEN; MITOMYCIN;

ADJUVANT CHEMOTHERAPY; ARTICLE; COLORECTAL TUMOR; HUMAN; HYPERTHERMIC THERAPY; INFUSION; METABOLISM; METASTASIS; METHODOLOGY; PATHOLOGY; PERITONEUM TUMOR; RECURRENT DISEASE; REGIONAL PERFUSION; RETROSPECTIVE STUDY;

ANTIBIOTICS, ANTINEOPLASTIC; CARCINOEMBRYONIC ANTIGEN; CHEMOTHERAPY, ADJUVANT; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; COLORECTAL NEOPLASMS; HUMANS; HYPERTHERMIA, INDUCED; INFUSIONS, PARENTERAL; MITOMYCIN; PERITONEAL NEOPLASMS; RECURRENCE; RETROSPECTIVE STUDIES;

EID: 0029687061     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02409050     Document Type: Article

References (28)

1. Griffin WD, Humphrey L, Sosin H. The prognosis and management of recurrent abdominal malignancies. Curr Probl Surg 1975;62:830-2.
2. Gunderson LL, Sosin H. Areas of failure found at reoperation (second or symptomatic look) following "curative surgery" for adenocarcinoma of the rectum: clinicopathologic correlation and implication for radiation therapy. Cancer 1974;4:1278-302.
3. Brenner DE. Intraperitoneal chemotherapy: a review. J Clin Oncol 1986;4:1135-47.
4. Cohen AM, Shank B, Friedmann MAX. Colorectal cancer. In: DeVita VT Jr, Hellman S, Rosenberg SA, eds. Cancer principles and practices of oncology. Philadelphia, PA: JB Lippincott, 1989:949-51.
5. Sugarbaker PH, Graves T, DeBruijn EA, et al. Early postoperative intraperitoneal chemotherapy as an adjuvant therapy to surgery for peritoneal carcinomatosis from gastrointestinal cancer: pharmacological studies. Cancer Res 1990; 50:5790-4.
6. Sugarbaker PH, Land D, Jaffe G, Pascal R. Histologic changes induced by intraperitoneal chemotherapy with 5-fluorouracil and mitomycin C in patients with peritoneal carcinomatosis from cystadenocarcinoma of the colon or appendix. Cancer 1990;65:1495-501.
7. Hojo K. Surgery for far-advanced colorectal cancer: extension of surgical indications and its results. Nippon Geka Gakkai Zasshi 1989;90:1428-31.
8. Cavaliere R, Ciocatto B, Giovanella B, et al. Selective heat sensitivity of cancer cells. Cancer 1967;20:1351-60.
9. Teicher BA, Kowal CD, Kennedy KA, Sartorelli AC. Enhancement by hyperthermia of the in vitro cytotoxicity of mitomycin C toward hypoxic tumor cells. Cancer Res 1981; 41:1096-9.
10. Spratt JS, Adcock RA, Muskovin M, Sherrill W, McKeown J. Clinical delivery system for intraperitoneal hyperthermic chemotherapy. Cancer Res 1980;40:256-60.
11. Fujimoto S, Shersha RD, Kokubun M, et al. Intraoperative hyperthermic perfusion combined with surgery effective for gastric cancer patients with peritoneal seeding. Ann Surg 1988;208:36-40.
12. Schneebaum S, Lange MK, Arnold MW, Ralston J, Dumond DA. Intraperitoneal hyperthermic perfusion for recurrent colorectal cancer - feasibility study. Reg Cancer 1992;4: 277-81.
13. Cohen CJ. Surgical considerations in ovarian cancer. Semin Oncol 1985;12 (suppl 4):53-6.
14. Markman M. Intraperitoneal chemotherapy. In: Perry MC, ed. The chemotherapy source book. Baltimore, MD: Williams & Wilkins, 1992:226-31.
15. Sugarbaker PH, Cundiffe WJ, Belliveau J, et al. Rationale for integrating early postoperative intraperitoneal chemotherapy into the surgical treatment of gastrointestinal cancer. Cancer Semin Oncol 1989;16:83-97.
16. Sugarbaker PH. Curative treatment of peritoneal carcinomatosis from grade I mucinous adenocarcinoma. Surg Rounds 1988;11:45-63.
17. Fujimoto S, Shersha RD, Kokubun M, et al. Clinical outcome of combined therapy of intraoperative hyperthermo-chemotherapy and surgery for patients with peritoneal recurrence from gastric cancer. Reg Cancer Treat 1990;3: 181-4.
18. Fujimoto S, Shersha RD, Kokubun M, et al. Clinical trial with surgery and intraperitoneal hyperthermic perfusion for peritoneal recurrence of gastrointestinal cancer. Cancer 1989;64:157-60.
19. Smith GV, McMillan R, Stribling J. Intraperitoneal approach to regional hyperthermia - possible anticancer applications. World J Surg 1983;7:732-7.
20. Lele PP. Thresholds and mechanisms of ultrasonic damage to organized animal tissues. In: Hazzard DG, Litz ML, eds. Symposium of biologic effects and characterization of ultrasound sources. Proceedings of a Conference in Rockville, Maryland, June 2-3, 1977. Bethesda, MD: HEW Publications (PDA) 78-8048:224.
21. Stehlin JS, Giovanella BC, de Ipolyi PD, Muenz LR, Anderson RF. Results of hyperthermic perfusion for melanoma of the extremities. Surg Gynecol Obstet 1975;140:339-68.
22. Fujimoto S, Kokubun M, Shrestha RD, et al. Prevention of scald injury on the peritoneo-serosal surface in advanced gastric cancer patients treated with intraperitoneal hyperthermic perfusion. Int J Hyperthermia 1991;7:543-50.
23. Fumagalli U, Trabucchi E, Soligo M, et al. Effects of intraperitoneal chemotherapy on anastomotic healing in the rat. J Surg Res 1991;50:82-7.
24. Engelmann U, Sonntag W, Jacobi GH. Influence of perioperative cis-platinum on breaking strength of bowel anastomoses in rats. Rec Res Cancer Res 1985;98:35.
25. Schneebaum S, Staubus AE, Asif M, Arnold M, Martin EW Jr. Pharmacokinetics of mitomycin C (MMC) during intraperitoneal hyperthermic perfusion (IPHP). In: Proceedings of the American Association for Cancer Research. San Diego, California, May 20-23, 1992. 1992;33:530.
26. Los G, Smals OAG, van Vugt MJH, van der Vlist M, den Engelse L, McVie JG, Pinedo HM. A rationale for carbon-platin treatment and abdominal hyperthermia in cancers restricted to the peritoneal cavity. Cancer Res 1992;52:1252-8.
27. Steis RG, Urba WJ, VanderMolen LA, et al. Intraperitoneal lymphokine-activated killer-cell and interleukin-2 therapy for malignancies limited to the peritoneal cavity. J Clin Oncol 1990:8:1618-29.
28. Song CW, Lin J-C, Lyons JC. Antitumor effect of interleukin lα in combination with hyperthermia. Cancer Res 1993;53,324-8.